NEW YORK (GenomeWeb News) — OncoMethylome will use BioTrove’s OpenArray PCR screening technology to develop gene-methylation cancer biomarkers, BioTrove said today.
 
Terms of the multi-year supply agreement call for BioTrove to provide its OpenArray nanoplates and instruments to help OncoMethylome study and develop DNA methylation-based biomarkers, BioTrove said.
 
OncoMethylome focuses on detecting cancer cells and using PCR tests to predict their response to treatments.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.